Skip to Menu Skip to Search Contact Us Skip to Content
US Flag

You are accessing SGS’s website from the USA.

Visit the US website instead

Stay on the global website and remember my choice

Our white papers and technical bulletins are written by industry experts from many different fields, exploring and commentating on a range of complex subjects.

Maxims for Early Phase Trials Maxims for Early Phase Trials

This white paper considers the importance of conducting safe, efficient, and productive early phase clinical trials and the options that are available to developers for study optimization.

Request a Copy

An Updated Approach to Extractables and Leachables Testing per ISO 10993–18:2020 An Updated Approach to Extractables and Leachables Testing per ISO 10993–18:2020

Medical devices must not adversely affect a patient’s safety. ISO 10993-18:2020 outlines how medical device manufacturers can test their products for potentially harmful chemicals leaching from the device materials.

Request a Copy

Nitrosamines: Questioning the Current Analytical Approach Nitrosamines: Questioning the Current Analytical Approach

In recent years, multiple drug products (DPs) have been recalled following the discovery of nitrosamine impurities. We look at current investigative methods and the potential for a more effective analytical approach.

Request a Copy

Cell Substrate Characterization In Vitro-based Virus Detection Methods Cell Substrate Characterization In Vitro-based Virus Detection Methods

This white paper explores how all components of commercial biopharmaceuticals and vaccines must undergo extensive safety testing to demonstrate identity, stability and purity.

Request a Copy

PowerS(h)elling SAS PowerS(h)elling SAS

A look at how Microsoft® PowerShell™ can be utilized to facilitate batch processing in SAS® and the benefits of creating a GUI, also using PowerShell, to configure and control SAS processes.

Request a Copy

Pharmacokinetic and Statistical Considerations in First-in-Human Clinical Trials - A Case Study Pharmacokinetic and Statistical Considerations in First-in-human Clinical Trials – Case Study

Given the exploratory nature of First-in-Human (FIH) studies, the question, "what, if any, statistical analysis is required for pharmacokinetics (PK) data?" has been asked before. This article investigates that question.

Request a Copy

Hard Brexit Is a Reality 4 Things Your Business Has to Do Right Now Hard Brexit Is a Reality: 4 Things Your Business Has to Do Right Now

Request a Copy

Decoding FSMA Certification A Practical Guide Decoding FSMA Certification – A Practical Guide

This document provides a practical guide to understanding FSMA certification.

Request a Copy

White paper thumbnail for Benefits of Integrating Full Characterization to Early Method Development - Focus on SEC-MALS Benefits of Integrating Full Characterization to Early Method Development - Focus on SEC-MALS

COVID-19 has highlighted the need for faster methodologies when developing new drug products. We look at how integrating the SEC-MALS method at an earlier stage in the development process will accelerate speed-to-clinic without compromising patient safety.

Request a Copy

Advancing the Detection of E&L by Pharma Manufacturers Advancing the Detection of E&L by Pharma Manufacturers

In this document, we look at how coupling the headspace sampling technique with an HRAM GC-MS system delivers a powerful technique to quickly assess and quantify potentially dangerous, untargeted volatile extractables in pharma workflows.

Request a Copy